Actinova AB
Active Biotech develops innovative pharmaceuticals that modulate the body's own immune system. We focus on widespread diseases for which a tremendous need is felt for new and more effective treatments...
www.actin.co.uk/ View full profile
| |
Active Biotech Research AB
Active Biotech focuses on developing pharmaceuticals for medical fields in which the immune system plays a central role.
Our pharmaceutical development is based on our specialist know-how...
www.activebiotech.com/ View full profile
| |
GenVec
GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines. Each of our gene-based therapeutic product candidates use a common patent...
www.genvec.com/ View full profile
| |
AMDL Incorporated
AMDL develops, manufactures, markets and sells various immunodiagnostic kits, used by laboratories in hospital, clinical, and research settings to obtain precise and rapid identification of certain...
www.amdl.com/ View full profile
| |
Lorus Therapeutics
Lorus Therapeutics Inc. is a pharmaceutical company focused on the development of cancer therapies. Lorus' goal is to capitalize on its pre-clinical, clinical and regulatory expertise by developing...
www.lorusthera.com/ View full profile
| |
OSI Pharmaceuticals
OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality of...
www.osip.com/ View full profile
| |
Rexahn Pharmaceuticals
Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of innovative treatments for cancer, central nervous system disorders...
www.rexahn.com/ View full profile
| |
Repligen
Repligen Corporation is a biotechnology company focused on developing new drugs for debilitating pediatric disorders including autism, immune and metabolic disorders. Repligen has exclusive worldwide...
www.repligen.com/ View full profile
| |
Agensys
Agensys, Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers based on its own proprietary targets. The Company has discovered and...
www.agensys.com/ View full profile
| |
AmpliMed Corporation
AmpliMed Corporation develops novel drugs for the treatment of cancer. Our lead product, Amplimexon™ (imexon inj.), has particular promise for the treatment of pancreatic cancer, malignant melanoma,...
www.amplimed.com/ View full profile
| |
Avantogen Oncology
Avantogen Limited is a drug development Company whose current activities are focused on its three product candidates, namely, RP101 (a potential therapy for pancreatic cancer), GPI-0100 (vaccine...
www.avantogen.com View full profile
| |
Beta-Cell
Beta-Cell is engaged in the development and commercialisation of innovative cell and drug therapies for the treatment of diabetes. The primary therapeutic focus of the company is on beta-cells, the...
www.beta-cell.com/ View full profile
| |
Betagenon AB
Betagenon has secured a strong, proprietary technology platform based upon the extensive research expertise on type 2 diabetes disease mechanisms established by the Founders, leading experts in the...
www.betagenon.com/ View full profile
| |
Digestive Associates of Houston
Digestive Associates of Houston, was founded by Dr. Isaac Raijman and Dr. Susana Escalante-Glorsky in February 2002. Our practice includes diagnostic and therapeutic management of gastrointestinal...
www.dahpa.com/ View full profile
| |
GlycoGenesys, Inc.
GlycoGenesys, Inc. is a biotechnology company that develops and licenses products based on glycobiology. The Company's human therapeutic product, GCS-100, a unique compound to treat cancer has been...
www.glycogenesys.com/ View full profile
| |
